Arkolith/Insider Trading/EKSO/Form 4/A

Sherman Steven

Executive ChairEKSO BIONICS HOLDINGS, INC. (EKSO) · full profile →Form 4/A · filed Jun 27, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 8, 2023Grant(A)84K—$0449K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001549084-23-000051) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML